I-Flow Expands Pain Management Portfolio With New Stimulating Needles For ON-Q T-bloc Trays

CHICAGO, April 3, 2014 /PRNewswire/ -- American Society of Regional Anesthesia and Acute Pain Medicine Meeting (ASRA) (Booth #101) –  I-Flow, LLC, a Kimberly-Clark Health Care Company and manufacturer of the ON-Q Pain Relief System (ON-Q), today announced the addition of premium echogenic stimulating Tuohy needles to its ON-Q T-bloc trays, providing additional guidance capabilities for peripheral nerve block placement.

ON-Q T-bloc trays and sets include needles, catheters and other pain management accessories, and are designed to aid in performing most continuous upper and lower extremity and truncal blocks. The new T-bloc trays will be on display during the American Society of Regional Anesthesia and Pain Medicine's (ASRA) 39th Annual Meeting, at the I-Flow booth (#101).

"The addition of echogenic stimulating Tuohy needles to our trays allows physicians to use ultrasound combined with nerve stimulation to achieve greater accuracy and better results," said Price St. Hilaire, Executive Director, Global Marketing, I-Flow. "This new offering represents I-Flow's commitment to providing healthcare professionals a total solution from one trusted partner."  

To request a trial of the new ON-Q T-bloc trays with stimulating needles, contact I-Flow customer service at 1-800-448-3569.

Additional I-Flow activity at ASRA includes:

Clinical Symposium

Admission is free and breakfast will be served. Participants may register online at: www.iflo.com/ASRAevent. 

Whitepaper Preview: ON-Q vs. Exparel for Pain Management

Executives from I-Flow will be at booth #101 to discuss findings of a new Frost & Sullivan whitepaper, documenting clinician perspective that ON-Q delivers superior pain control over the full length of the post-operative period – and at a lower cost – compared to Exparel.

Findings from the research include:

• According to anesthesiologists involved in the research, the actual duration of pain relief for Exparel was significantly shorter than marketed – 25 versus 72 hours. While Exparel provided better pain relief up to 12 hours, ON-Q provided superior pain relief from that point forward up to 96 hours, making it the ideal choice for longer-term pain management.

• The anesthesiologists surveyed indicated that they experienced a greater reduction in narcotic use when using ON-Q, with 58 percent experiencing a major reduction, compared to just 35 percent for Exparel.

• Hospitals are performing a greater percentage of orthopedic surgery cases using ON-Q (37 percent) and a lower percentage using Exparel (31 percent). Anesthesiologists reported the highest percentage of orthopedic cases (39 percent) using ON-Q.

About I-Flow
I-Flow, LLC, a Kimberly-Clark Health Care Company, is a global market leader in acute pain and ambulatory medication delivery, driving innovative clinical applications for surgical procedures and regional anesthesia that improve outcomes and advance patient care. Led by its surgical pain management line, the ON-Q Pain Relief System (ON-Q) provides reliable and simple non-narcotic, regional anesthesia therapies that are redefining post-surgical recovery by reducing many of the side effects customarily associated with narcotics. Clinical studies have shown that patients who receive ON-Q products generally get back to normal faster after surgery, resulting in shorter hospital stays, reduced costs and higher patient satisfaction. I-Flow also offers a comprehensive suite of sets and trays for performing peripheral nerve blocks, providing an unmet need and total product solution for I-Flow's clinician customers. Also as part of I-Flow's total solution, the Company offers in-depth training, education, consulting and clinical support along with medical device expertise. For more information, visit www.iflo.com.  

SOURCE I-Flow, LLC